About the Authors

Zachary A. Klase

Affiliation Department of Biological Sciences, University of the Sciences, Philadelphia, Pennsylvania, United States of America

Svetlana Khakhina

Affiliation Department of Biological Sciences, University of the Sciences, Philadelphia, Pennsylvania, United States of America

Adriano De Bernardi Schneider

Affiliation Department of Bioinformatics and Genomics, University of North Carolina at Charlotte, Charlotte, North Carolina, United States of America

Michael V. Callahan

Affiliations Department of Medicine, Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, United States of America, Zika Foundation, College Station, Texas, United States of America

Jill Glasspool-Malone

Affiliations Atheric Pharmaceutical, Scottsville, Virginia, United States of America, Global Clinical Scholars Research Training Program, Harvard Medical School, Boston, Massachusetts, United States of America

Robert Malone

RWMaloneMD@gmail.com

Affiliations Atheric Pharmaceutical, Scottsville, Virginia, United States of America, Global Clinical Scholars Research Training Program, Harvard Medical School, Boston, Massachusetts, United States of America

Competing Interests

I have read the journal's policy and the authors of this manuscript have the following competing interests: Drs. Robert Malone and Jill Glasspool-Malone are principal stockholders of Atheric Pharmaceutical, LLC. Robert Malone is the managing partner of Atheric Pharmaceutical. Dr. Michael Callahan is the Chief Medical Officer of the Zika Foundation.